EBR Systems, Inc.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a EBR.AX research report →
Price Chart
About the company
EBR Systems, Inc. is a company focused on creating implantable medical devices that employ wireless technology for tissue stimulation. Their flagship product is the WiSE cardiac resynchronization therapy system, which utilizes a unique wireless method to deliver pacing signals directly inside the left ventricle of the heart.
- CEO
- John Graham McCutcheon
- IPO
- 2021
- Employees
- 135
- HQ
- Sunnyvale, CA, US
Get TickerSpark's AI analysis on EBR.AX
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Similar companies
Peers in the same neighborhood.
- Market Cap
- $124.47M
- P/E
- -2.03
- Fwd P/E
- 1.46
- PEG
- -0.12
- P/S
- 14.01
- P/B
- 1.41
- EV/EBITDA
- -1.61
- Div Yield
- 0.00%
- Gross Margin
- 14.52%
- Op Margin
- -900.44%
- Net Margin
- -947.48%
- ROE
- -169.40%
- ROIC
- -44.57%
Latest fiscal year · YoY change
- Revenue
- $1.67M+0.0%
- Gross Profit
- $507.09K+0.0%
- Op Income
- $-47,694,180
- Net Income
- $-50,458,325-150.1%
- EPS
- $-0.12-85.2%
- OCF Growth
- -33.5%
- FCF Growth
- -41.8%
- 52W High
- $1.47
- 52W Low
- $0.24
- 50D MA
- $0.34
- 200D MA
- $0.66
- Beta
- 0.52
- RSI (14)
- 41
- Avg Volume
- 3.10M
No earnings-call transcripts are available for EBR.AX yet.
- Free Float
- 79.0%
- Shares Outstanding
- 452.62M
- Float Shares
- 357.51M
Our EBR.AX coverage
Recent articles, reports, and earnings notes.
No research on EBR.AX yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate EBR.AX report →